333 related articles for article (PubMed ID: 37484811)
1. Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte.
Chen Z; Li R; Fang M; Wang Y; Bi A; Yang L; Song T; Li Y; Li Q; Lin B; Jia Y; Fu S; Fu S; Xiong H
Int J Med Sci; 2023; 20(8):1060-1078. PubMed ID: 37484811
[No Abstract] [Full Text] [Related]
2. Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization.
Xiong H; Zhai Y; Meng Y; Wu Z; Qiu A; Cai Y; Wang G; Yang L
Cancer Lett; 2024 Apr; 587():216732. PubMed ID: 38360142
[TBL] [Abstract][Full Text] [Related]
3. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.
El Ansari R; Craze ML; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Br J Cancer; 2018 Apr; 118(8):1115-1122. PubMed ID: 29545595
[TBL] [Abstract][Full Text] [Related]
4. Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Alfarsi LH; El-Ansari R; Craze ML; Masisi BK; Mohammed OJ; Ellis IO; Rakha EA; Green AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093034
[TBL] [Abstract][Full Text] [Related]
5. SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway.
Wu F; Xiong G; Chen Z; Lei C; Liu Q; Bai Y
Hereditas; 2022 Jan; 159(1):6. PubMed ID: 35057861
[TBL] [Abstract][Full Text] [Related]
6. Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.
Wu P; Zhao L; Kong G; Song B
Technol Cancer Res Treat; 2024; 23():15330338241246649. PubMed ID: 38656249
[No Abstract] [Full Text] [Related]
7. The prognostic and immunological role of FKBP1A in an integrated muti-omics cancers analysis, especially lung cancer.
Zhang Y; Xu H; Pi S; Tan H; Huang B; Chen Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16589-16608. PubMed ID: 37715833
[TBL] [Abstract][Full Text] [Related]
8. The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.
El-Ansari R; Craze ML; Alfarsi L; Soria D; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 May; 175(1):27-38. PubMed ID: 30671766
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
Tang W; Xu F; Zhao M; Zhang S
BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
[TBL] [Abstract][Full Text] [Related]
10. Identification of SLC3A2 as a Potential Therapeutic Target of Osteoarthritis Involved in Ferroptosis by Integrating Bioinformatics, Clinical Factors and Experiments.
Liu H; Deng Z; Yu B; Liu H; Yang Z; Zeng A; Fu M
Cells; 2022 Oct; 11(21):. PubMed ID: 36359826
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing.
Zhang J; Xiang F; Ding Y; Hu W; Wang H; Zhang X; Lei Z; Li T; Wang P; Kang X
BMC Genomics; 2024 Mar; 25(1):236. PubMed ID: 38438962
[TBL] [Abstract][Full Text] [Related]
12. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
Wang Y; Xu Y; Zhang Y
Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
[TBL] [Abstract][Full Text] [Related]
14. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
Digomann D; Linge A; Dubrovska A
Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
[TBL] [Abstract][Full Text] [Related]
15. Targeting SLC3A2 subunit of system X
Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
[TBL] [Abstract][Full Text] [Related]
16. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
17. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
18. Ancient dormant virus remnant ERVW-1 drives ferroptosis via degradation of GPX4 and SLC3A2 in schizophrenia.
Zhang D; Wu X; Xue X; Li W; Zhou P; Lv Z; Zhao K; Zhu F
Virol Sin; 2024 Feb; 39(1):31-43. PubMed ID: 37690733
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
Nguyen NNT; Lim YS; Nguyen LP; Tran SC; Luong TTD; Nguyen TTT; Pham HT; Mai HN; Choi JW; Han SS; Hwang SB
Sci Rep; 2018 Oct; 8(1):15486. PubMed ID: 30341327
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors.
He J; Liu D; Liu M; Tang R; Zhang D
Front Mol Biosci; 2022; 9():961410. PubMed ID: 35992269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
